Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 14,104

Document Document Title
WO/2012/014818A1
Disclosed are the following ether compound, and the use of the same. In formula (1), n represents 0 or 1, m represents an integer of 0-2, Y represents -O-, -S-, -C (=O) -O- and -O- C (=O) -, X1 and X2 represent a hydrogen atom or a fluor...  
WO/2012/014181A1
The invention relates to compounds of formula (I) for use in the prevention and/or treatment of viral infections: Wherein X, Y, Z, T, R1a and R1b are as defined in claim 1.  
WO/2012/015616A1
Methods for the production of dehydrated sugars and derivatives of dehydrated sugars using microwave (MW) irradiation and methods of purifying the same are described. The dehydrated sugars derivatives include 5-hydroxymethyl-2-furfural (...  
WO/2012/013016A1
The invention relates to the field of medicine. Curcumalactone derivatives with antitumor activity and the process for their preparation are disclosed. The said curcumalactone derivatives and their oxidized derivatives have a spironolact...  
WO/2012/014779A1
Disclosed is an organic electroluminescent element having the following attributes in high degree: high luminous efficiency, durability, low drive voltage, and inhibition of decreased luminous efficiency after high-temperature storage. A...  
WO/2012/010174A1
The present invention is concerned with a process in connection with the purification of a pharmaceutically acceptable salt of escitalopram or citalopram.  
WO/2012/012278A2
Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treat...  
WO/2012/012278A3
Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treat...  
WO/2012/010802A1
The invention relates to a process for preparing benzofuran derivatives of general formula I, in which R represents a nitro or ester-COOR' group, where R' represents an alkyl group, R1 represents hydrogen or an alkyl group and R2 represe...  
WO/2012/010555A1
The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/ NF-ĸΒ signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising s...  
WO/2012/010788A1
The invention relates to a process for preparing 5-aminobenzoylbenzofuran derivatives of formula (I), in which R1 represents hydrogen or an alkyl group and R2 represents hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group, by reductio...  
WO/2012/011128A1
A process for preparing the prostaglandin derivatives is provided, wherein the benzoyl and p-nitrobenzoyl groups are used as the hydroxyl protective groups. A pharmaceutical composition comprising the prostaglandin derivatives is also pr...  
WO/2012/011125A1
The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are therefore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for thei...  
WO/2012/010579A3
The present invention relates to fungicidal benzocycloalkene carboxamides or their thiocarboxamide derivatives of formula (I), their process of preparation and intermediate compounds for their preparation, their use as fungicides, partic...  
WO/2012/010913A1
The subject of the invention is a novel process for the preparation of N-[2-n-butyl-3-{4-[(3-di-n-butylamino)- propoxy]benzoyl}benzofuran-5-yl]-methanesulfonamide of formula (I), and pharmaceutically acceptable salts thereof characterize...  
WO/2012/009609A1
The invention provides for new flame retardant non-furan dicarboxylic acid (FDCA) based polyols; oligomers and polymers made from these new polyols with flame retardation properties; and methods of using them as a part or all of the flam...  
WO/2012/006686A1
The present invention relates to the scaled-up synthesis of biologically active compounds which display useful therapeutic activity in treating proliferative disorders. In particular the invention relates to process methods for the kilog...  
WO/2012/007959A1
Disclosed is a process for preparing dronedarone and pharmaceutically acceptable salts thereof. Also disclosed are a novel amorphous form of dronedarone hydrochloride and a preparation process thereof.  
WO/2012/008435A1
Disclosed is a novel biaryl amide derivative represented by formula (1) and having an affinity for the aldosterone receptor; also disclosed is a pharmaceutically acceptable salt thereof. (In the formula, A is any of the groups represente...  
WO/2012/004658A2
The present invention relates to a process for the preparation of highly pure N-[2- butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5- benzofuranyljmethanesulfonamide and pharmaceutically acceptable salts thereof having HPLC purity greater ...  
WO/2012/005200A1
An industrially advantageous method for producing an optically active 1,2-bis(dialkylphosphino)benzene derivative, wherein borane is removed from a phosphine-borane compound (1), followed by lithiation, then the reaction product is react...  
WO/2012/004658A3
The present invention relates to a process for the preparation of highly pure N- [2- butyl -3- [4- [3- (dibutylamino) propoxy] benzoyl] -5- benzofuranyljmethanesulfonamide and pharmaceutically acceptable salts thereof having HPLC purity ...  
WO/2012/004069A1
The invention relates to a process for producing compounds of the general formula (I) from compounds of the general formula (IIa) and/or (IIb) with an oxygen-containing gas in the presence of a catalyst composition, the reaction taking p...  
WO/2012/004658A8
The present invention relates to a process for the preparation of highly pure N-[2- butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5- benzofuranyljmethanesulfonamide and pharmaceutically acceptable salts thereof having HPLC purity greater ...  
WO/2012/002203A1
Disclosed is a production method for obtaining an optically active β-aminocarbonyl compound by a Mannich reaction of an aldimine in which nitrogen is protected and a malonic acid diester, in the presence of optically active BINOL and 1-...  
WO/2012/003164A1
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity agamst hepatitis C virus (HCV) and may be useful in treating those infected wi...  
WO/2012/002512A1
A polymerisable compound having a terminal having an α-methylene-γ-butyrolactone group and a terminal having a photopolymer or a photocrosslinking group; a polymer for forming a liquid crystal aligning agent capable of aligning liquid ...  
WO/2012/002513A1
Disclosed is a polymerizable compound represented by formula (1). In formula (1), V represents a single bond or -R1O-, wherein R1 represents a linear or branched alkylene group having 1 to 10 carbon atoms, and W represents a single bond ...  
WO/2012/002511A1
The liquid crystal-aligning agent comprises polyimide precursor with side chains that vertically orient liquid crystals and photoreactive side chains that contain at least one kind selected from methacrylic, acrylic, vinyl and cinnamoyl ...  
WO/2012/002527A1
Provided are a novel heterocyclic compound and salt thereof applicable in the selective inhibition of the degradation of p27Kip1. The compound and the salt thereof are represented in formula (1). [In the formula: A represents an alkyl gr...  
WO/2012/001148A1
The present invention relates to calcium salts of compounds of the general formula (I) wherein X is selected from the group consisting of CH2, S, or O; D is O or S; R8 is hydrogen or alkyl; E is an optionally substituted phenylene group;...  
WO/2012/001151A1
The present invention relates to a salt selected from the group comprising the N-methyl-D- glucamine salt (NMG), the diethylamine salt (DEA) salt, the magnesium salt, the tromethamine salt, the choline salt, the L-arginine salt, the zinc...  
WO/2012/000608A2
The present invention relates to novel beta-aminoaldehyde derivatives of the formulae (I), (II) and (III), in which the substituents R1 to R5 and A have the meaning given in the description, to a novel process for their preparation, to i...  
WO/2012/001620A1
The present invention relates to a multilayer catalyst for preparing phthalic anhydride which has a plurality of catalyst layers arranged in succession in the reaction tube, with the individual catalyst layers having alkali metal content...  
WO/2012/000608A3
The present invention relates to novel beta-aminoaldehyde derivatives of the formulae (I), (II) and (III), in which the substituents R1 to R5 and A have the meaning given in the description, to a novel process for their preparation, to i...  
WO/2011/161945A1
Disclosed are a new alkoxyimino derivative or an agriculturally acceptable salt thereof and a pest control agent containing as an active ingredient the derivative or a salt thereof, wherein the agent shows an excellent controlling effect...  
WO/2011/161141A1
A process for separating furfural from a liquid aqueous phase comprising furfural and one or more organic acids, which process comprises a step a) extracting furfural from the liquid aqueous phase into a liquid aromatic phase comprising ...  
WO/2011/161201A1
A compound of formula (I). The compound is useful for treating cancer and inflammatory diseases. A pharmaceutical composition containing the compound.  
WO/2011/163610A2
The invention provides a compound of formula I:or a salt thereof, wherein R3-R8 and X and Y have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as an...  
WO/2011/163610A3
The invention provides a compound of formula I:or a salt thereof, wherein R3-R8 and X and Y have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as an...  
WO/2011/158050A1
This invention relates to a process for the preparation of N-[2-n-butyl-3-{4-[(3- dibutylamino)-propoxy]-benzoyl} - 1-benzofuran-5-yl]-methane-sulfonamide of formula (I) and its pharmaceutically acceptable salts, according to one of the ...  
WO/2011/159297A1
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.  
WO/2011/158928A1
Provided is a process for efficiently producing a trimellitic anhydride phenyl ester in high yield. The process for producing a trimellitic anhydride phenyl ester comprises subjecting a carboxylic acid phenyl ester and trimellitic anhydr...  
WO/2011/159781A3
The present invention includes antagonists of human type 2 taste receptors (hT2Rs) having structural Formula (I). The present invention also provides compositions containing these antagonists, the use of these antagonists for modulating ...  
WO/2011/157790A1
The present invention provides an organic electronic device including a first electrode, a second electrode, and an organic layer interposed between the first electrode and the second electrode, wherein the organic layer comprises an org...  
WO/2011/159781A2
The present invention includes antagonists of human type 2 taste receptors (hT2Rs) having structural Formula (I). The present invention also provides compositions containing these antagonists, the use of these antagonists for modulating ...  
WO/2011/158178A1
The instant invention relates to a method of determining whether to administer to a patient dronedarone, or a pharmaceutically acceptable salt thereof, in combination with a potassium-depleting diuretic for the treatment of arrhythmia co...  
WO/2011/158249A1
Disclosed is a process for the preparation of milnacipran intermediate, a compound of formula ΙII, and its use in the preparation of pure milnacipran.  
WO/2011/158333A1
The present invention provides a method for synthesizing a zederone analogue derived from natural materials, a precursor useful in synthesis of the zederone analogue, and an intermediate useful for synthesizing the zederone precursor. Sp...  
WO/2011/156321A9
Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, p...  

Matches 701 - 750 out of 14,104